The fate of adenovirus type 7 deosyribonucleic acid during treatment of the virus with formamide.
D000256:Adenoviridae / Q000187:drug effects* / Q000472:pathogenicity; D000577:Amides / Q000494:pharmacology*; D000596:Amino Acids / Q000378:metabolism; D002247:Carbon Isotopes; D002460:Cell Line; D002499:Centrifugation, Density Gradient; D002501:Centrifugation, Zonal; D002586:Cesium; D011232:Chemical Precipitation; D002712:Chlorides; D002850:Chromatography, Gel; D003588:Cytopathogenic Effect, Viral; D004279:DNA, Viral / Q000032:analysis; D005559:Formamides / Q000494:pharmacology; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007668:Kidney; D010179:Pancreas; D000644:Quaternary Ammonium Compounds; D012260:Ribonucleases / Q000494:pharmacology; D012965:Sodium Chloride; D012997:Solvents / Q000494:pharmacology*; D013395:Sucrose; D013431:Sulfates; D013696:Temperature; D013936:Thymidine / Q000378:metabolism; D013997:Time Factors; D014316:Tritium
D000577:Amides; D000596:Amino Acids; D002247:Carbon Isotopes; D002712:Chlorides; D004279:DNA, Viral; D005559:Formamides; D000644:Quaternary Ammonium Compounds; D012997:Solvents; D013431:Sulfates; D014316:Tritium; D002586:Cesium; D012965:Sodium Chloride; D013395:Sucrose; D012260:Ribonucleases; D013936:Thymidine